InvestSMART

Mesoblast Limited (ASX: MSB) - Announcements

- Current share price for MSB : $2.380

ASX company news and announcements for Mesoblast Limited (MSB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Mesoblast Limited (MSB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Mesoblast Limited (MSB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Mesoblast Limited (MSB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$3,091 MSB Annual Financial Results and Operational Update 27 Aug 2026 8:39AM $2.360 $2.380 risen by 0.85%
$3,091 Annual Financial Results Presentation 27 Aug 2026 8:33AM $2.360 $2.380 risen by 0.85%
$3,091 Preliminary Final Report including Appendix 4E 27 Aug 2026 8:21AM $2.360 $2.380 risen by 0.85%
$3,091 Appendix 3Y - Philip Krause 24 Aug 2026 5:50PM $2.350 $2.380 risen by 1.28%
$3,091 Notification regarding unquoted securities - MSB 24 Aug 2026 5:40PM $2.350 $2.380 risen by 1.28%
$3,091 Mesoblast 2026 Full Year Financial Results Webcast 24 Aug 2026 5:38PM $2.350 $2.380 risen by 1.28%
$3,091 Major Milestone Treatment Completed in P3 Trial for CLBP 17 Aug 2026 10:00AM $2.200 $2.380 risen by 8.18%
$3,091 Becoming a substantial holder 13 Aug 2026 5:52PM $2.380 $2.380 fallen by 0%
$3,091 Ceasing to be a substantial holder 7 Aug 2026 5:02PM $2.230 $2.380 risen by 6.73%
$3,091 Becoming a substantial holder 5 Aug 2026 6:29PM $2.130 $2.380 risen by 11.74%
$3,091 Ceasing to be a substantial holder 3 Aug 2026 5:25PM $2.030 $2.380 risen by 17.24%
$3,091 Becoming a substantial holder 31 Jul 2026 5:06PM $2.050 $2.380 risen by 16.10%
$3,091 Quarterly Activities/Appendix 4C Cash Flow Report 30 Jul 2026 10:01AM $2.010 $2.380 risen by 18.41%
$3,091 Ceasing to be a substantial holder 24 Jul 2026 5:00PM $2.220 $2.380 risen by 7.21%
$3,091 Ceasing to be a substantial holder 22 Jul 2026 8:23AM $2.320 $2.380 risen by 2.59%
$3,091 Mesoblast CEO Makes Investment to Increase Share Ownership 21 Jul 2026 9:53AM $2.430 $2.380 fallen by 2.06%
$3,091 Appendix 3Y - Silviu Itescu 21 Jul 2026 9:47AM $2.430 $2.380 fallen by 2.06%
$3,091 Notification regarding unquoted securities - MSB 21 Jul 2026 9:43AM $2.430 $2.380 fallen by 2.06%
$3,091 Application for quotation of securities - MSB 21 Jul 2026 9:33AM $2.430 $2.380 fallen by 2.06%
$3,091 Notification of cessation of securities - MSB 14 Jul 2026 5:31PM $2.380 $2.380 fallen by 0%
$3,091 Notification regarding unquoted securities - MSB 14 Jul 2026 5:25PM $2.380 $2.380 fallen by 0%
$3,091 Application for quotation of securities - MSB 14 Jul 2026 5:21PM $2.380 $2.380 fallen by 0%
$3,091 Notification regarding unquoted securities - MSB 14 Jul 2026 5:15PM $2.380 $2.380 fallen by 0%
$3,091 Appendix 3Y - Silviu Itescu 14 Jul 2026 5:12PM $2.380 $2.380 fallen by 0%
$3,091 Pivotal Phase 3 Trial in CLBP Achieves 300 Treated Patients 14 Jul 2026 10:00AM $2.320 $2.380 risen by 2.59%

1 - 25 of 1186 results

Page 1 of 48

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.